Free Trial

BioNTech (BNTX) Earnings Date, Estimates & Call Transcripts

BioNTech logo
$106.40 +4.53 (+4.45%)
(As of 11/19/2024 ET)

BioNTech Latest Earnings Summary

Upcoming Q4
Earnings Date
Mar. 19Estimated
Actual EPS
(Nov. 4)
$0.81 Beat By $2.07
Consensus EPS
(Nov. 4)
-$1.26

BioNTech issued Q3 2024 earnings on November 4, 2024, reporting an EPS of $0.81, which beat analysts' consensus estimates of -$1.26 by $2.07. Quarterly revenue rose 38.9% year-over-year to $1.24 billion, above analyst estimates of $514.08 million. With a trailing EPS of -$2.10, BioNTech's earnings are expected to decrease next year, from ($3.68) to ($4.20) per share.

BNTX Upcoming Earnings

BioNTech's next earnings date is estimated for Wednesday, March 19, 2025, based off prior year's reporting schedules.

Get BioNTech Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioNTech and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BNTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BNTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioNTech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243-$1.02$1.26-$0.08
Q2 20243-$1.76-$1.05-$1.35
Q3 20243-$1.33$2.98$0.79
Q4 20243$0.06$2.76$1.08
FY 202412-$4.05$5.95$0.44
Q1 20252-$3.42-$1.81-$2.62
Q2 20252-$3.50-$2.30-$2.90
Q3 20252$0.26$2.20$1.23
Q4 20252$0.19$1.85$1.02
FY 20258($6.47)($0.06)($3.27)

BioNTech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/19/2025
(Estimated)
------- 
11/4/2024Q3 2024-$1.26$0.81+$2.07$0.89$514.08M$1.24B        
8/5/2024Q2 2024-$2.02-$3.36 -$1.34-$3.62$134.98M$128.70M        
5/6/2024Q1 2024-$0.82-$1.42 -$0.60-$1.42$589.96M$203.69M    
3/20/2024Q4 2023$2.64$2.05 -$0.59$2.05$2.04B$1.59B    
11/6/2023Q3 2023-$0.59$0.67+$1.26$0.73$850.50M$895.30M        
8/7/2023Q2 2023-$0.83-$0.79+$0.04-$0.86$628.13M$167.70M        
5/8/2023Q1 2023$0.18$2.05+$1.87$2.20$1.09B$1.28B        
3/27/2023Q4 2022$8.04$9.26+$1.22$9.46$3.87B$4.28B        

BioNTech Earnings - Frequently Asked Questions

BioNTech has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based off last year's report dates. Learn more on BNTX's earnings history.

BioNTech issued an update on its FY 2024 earnings guidance on Monday, November, 4th. The company issued revenue guidance of $2.7 billion-$2.7 billion, compared to the consensus revenue estimate of $2.6 billion.

In the previous quarter, BioNTech (NASDAQ:BNTX) reported $0.81 earnings per share (EPS) to beat the analysts' consensus estimate of ($1.26) by $2.07. Learn more on analysts' earnings estimate vs. BNTX's actual earnings.

The conference call for BioNTech's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for BioNTech's latest earnings report can be read online.
Read Transcript

BioNTech (NASDAQ:BNTX) has a recorded annual revenue of $3.04 billion.

BioNTech (NASDAQ:BNTX) has a recorded net income of $1.01 billion. BNTX has generated -$2.10 earnings per share over the last four quarters.

BioNTech's earnings are expected to decrease from ($3.68) per share to ($4.20) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:BNTX) was last updated on 11/19/2024 by MarketBeat.com Staff
From Our Partners